DXCM250509P110000
- 0.00
- 0.000.00%
DexCom Newsroom
DexCom (DXCM) Jumps 15% After Q1 Revenue Beat, $750M Buyback
Barclays Maintains Equal-Weight on DexCom, Raises Price Target to $93
Duolingo, CoreWeave And DexCom Are Among Top 10 Large-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
A Quick Look at Today's Ratings for DexCom(DXCM.US), With a Forecast Between $88 to $109
Why DexCom, Inc. (DXCM) Went Up On Friday
DexCom's Earnings Call: Growth Amid Challenges
Top Gap Ups and Downs on Friday: AAPL, MSI, ING and More
US Equities Markets End Higher Friday as US Adds More Jobs Than Expected
Equity Markets Rise After Nonfarm Payrolls Beat Expectations
Sector Update: Health Care
Research Alert: CFRA Maintains Hold Recommendation On Shares Of Dexcom, Inc.
Jobs Report Helps Boost Equities Intraday; Apple Falls
Top Midday Gainers
DexCom (NasdaqGS:DXCM) Announces US$750M Buyback and Reiterates 2025 Earnings Guidance
Dexcom Stock Is Today's Big Winner After Earnings. Why the Medtech Is Soaring. -- Barrons.com
DexCom Price Target Cut to $90.00/Share From $100.00 by Piper Sandler
DexCom Is Maintained at Overweight by Piper Sandler
Citigroup Adjusts Price Target on DexCom to $82 From $80
BTIG Adjusts Price Target on DexCom to $109 From $107
DexCom Up Over 14%, on Track for Largest Percent Increase Since October 2022 -- Data Talk